Cargando…

Contemporary Drug Therapy for Renal Cell Carcinoma—Evidence Accumulation and Histological Implications in Treatment Strategy

Renal cell carcinoma (RCC) is a heterogeneous disease comprising a variety of histological subtypes. Approximately 70–80% of RCC cases are clear cell carcinoma (ccRCC), while the remaining subtypes constitute non-clear cell carcinoma (nccRCC). The medical treatment of RCC has greatly changed in rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamana, Kazutoshi, Ohashi, Riuko, Tomita, Yoshihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687261/ https://www.ncbi.nlm.nih.gov/pubmed/36359359 http://dx.doi.org/10.3390/biomedicines10112840

Ejemplares similares

Efficacy and safety of subsequent molecular targeted therapy after immuno-checkpoint therapy, retrospective study of Japanese patients with metastatic renal cell carcinoma (AFTER I-O study)
por: Tomita, Yoshihiko, et al.
Publicado: (2021)

Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma
por: Tomita, Yoshihiko, et al.
Publicado: (2021)

Erratum to: Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma
por: Tomita, Yoshihiko, et al.
Publicado: (2021)

Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features
por: Sircar, Kanishka, et al.
Publicado: (2013)

Congenital Scaphoid Megalourethra: A Case Report
por: Obara, Kenji, et al.
Publicado: (2017)

The Morphological Spectrum of Papillary Renal Cell Carcinoma and Prevalence of Provisional/Emerging Renal Tumor Entities with Papillary Growth
por: Lobo, João, et al.
Publicado: (2021)

Histologic-Based Tumor-Associated Immune Cells Status in Clear Cell Renal Cell Carcinoma Correlates with Gene Signatures Related to Cancer Immunity and Clinical Outcomes
por: Ohe, Chisato, et al.
Publicado: (2022)

Solitary brain metastasis from prostate cancer after multi modality treatment: A case report
por: Ishizaki, Fumio, et al.
Publicado: (2019)

Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients
por: Itoi, T, et al.
Publicado: (2004)

Histologic Heterogeneity of Extirpated Renal Cell Carcinoma Specimens: Implications for Renal Mass Biopsy
por: Nahouraii, Lauren M., et al.
Publicado: (2020)

Contemporary Strategies in the Management of Hepatocellular Carcinoma
por: Khorsandi, Shirin Elizabeth, et al.
Publicado: (2012)

Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma
por: Ohashi, Riuko, et al.
Publicado: (2019)

Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients
por: Ohashi, Riuko, et al.
Publicado: (2020)

Ulcerative interstitial cystitis in an adolescent successfully treated with complete transurethral ulcer resection: A case report
por: Yuki, Eri, et al.
Publicado: (2018)

Contemporary Treatment of Metastatic Renal Cell Carcinoma
por: Stukalin, Igor, et al.
Publicado: (2016)

Electronic evidence: strategies for managing records in contemporary organizations
por: Bearman, David
Publicado: (1994)

Drug repurposing: An effective strategy to accelerate contemporary drug discovery
por: Zhan, Peng, et al.
Publicado: (2022)

Innervation of the hip joint capsular complex: A systematic review of histological and immunohistochemical studies and their clinical implications for contemporary treatment strategies in total hip arthroplasty
por: Tomlinson, Joanna, et al.
Publicado: (2020)

TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background
por: Pivovarcikova, Kristyna, et al.
Publicado: (2022)

Development of patient-derived tumor organoids and a drug testing model for renal cell carcinoma
por: Kazama, Akira, et al.
Publicado: (2021)

Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma
por: Maruyama, R, et al.
Publicado: (2006)

Contemporary Strategy Analysis
por: Grant, Robert
Publicado: (2018)

Biochemical and histological evidence of deteriorated bioprosthetic valve leaflets: the accumulation of fibrinogen and plasminogen
por: Sakaue, Tomohisa, et al.
Publicado: (2018)

Synchronous Occurrence of Advanced Gastric Carcinoma with Retroperitoneal Liposarcoma: A Case Report
por: Kobayashi, Hiroshi, et al.
Publicado: (2022)

Clinicopathological features of non-conventional renal cell carcinoma histological subtypes: Learning points from a large contemporary series spanning over three decades
por: Lim, Ee Jean, et al.
Publicado: (2022)

Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter
por: Bianconi, Maristella, et al.
Publicado: (2019)

The role of open radical nephrectomy in contemporary management of renal cell carcinoma
por: Kalapara, Arveen A., et al.
Publicado: (2020)

Computed Tomography Imaging Characteristics of Histologically Confirmed Papillary Renal Cell Carcinoma—Implications for Ancillary Imaging
por: Walker, Jeffrey B., et al.
Publicado: (2019)

PSMA-Expression Is Highly Associated with Histological Subtypes of Renal Cell Carcinoma: Potential Implications for Theranostic Approaches
por: Bui, Vinh Ngoc, et al.
Publicado: (2023)

Immunotherapy in renal cell carcinoma: latest evidence and clinical implications
por: Santoni, Matteo, et al.
Publicado: (2018)

Development and evaluation of a deep neural network for histologic classification of renal cell carcinoma on biopsy and surgical resection slides
por: Zhu, Mengdan, et al.
Publicado: (2021)

Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications
por: Abel, Stephen, et al.
Publicado: (2019)

Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma
por: Navani, Vishal, et al.
Publicado: (2022)

Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma()
por: Bihr, Svenja, et al.
Publicado: (2019)

Racial difference in histologic subtype of renal cell carcinoma
por: Olshan, Andrew F, et al.
Publicado: (2013)

Synchronous bilateral renal cell carcinomas with differing histologies
por: Shigehisa, Ryu, et al.
Publicado: (2020)

Renal Histologic Parameters Influencing Postoperative Renal Function in Renal Cell Carcinoma Patients
por: Koh, Myoung Ju, et al.
Publicado: (2013)

Saponin Facilitates Anti-Robo1 Immunotoxin Cytotoxic Effects on Maxillary Sinus Squamous Cell Carcinoma
por: Komatsu, Noriko, et al.
Publicado: (2020)

Clinical implication of ectopic liver lipid accumulation in renal cell carcinoma patients without visceral obesity
por: Watanabe, Daisuke, et al.
Publicado: (2017)

A Thought Experiment in Contemporary Drug Development: Informed Bench‐to‐Bedside Strategies
por: Becker, Richard C.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k6nqm2psd38j98s4d417ljp1e7